The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rapid, real-time central pathology review for E1412: A novel and successful paradigm for future National Clinical Trials Network diffuse large B cell lymphoma studies.
 
Rebecca L. King
No Relationships to Disclose
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene; MorphoSys
Research Funding - Celgene (Inst)
 
Thomas E. Witzig
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
Consulting or Advisory Role - Celgene; Seagen
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Novartis (Inst); Spectrum Pharmaceuticals (Inst)
 
David W. Scott
Honoraria - Roche
Consulting or Advisory Role - Celgene; Janssen
Patents, Royalties, Other Intellectual Property - NanoString Technologies
 
Richard F. Little
No Relationships to Disclose
 
Fangxin Hong
No Relationships to Disclose
 
Randy D. Gascoyne
Patents, Royalties, Other Intellectual Property - NanoString Technologies
 
Brad S. Kahl
Consulting or Advisory Role - Abbvie; Acerta Pharma; Celgene; Cell Therapeutics; Genentech/Roche; incyte; Infinity Pharmaceuticals; Juno Therapeutics; Millennium; Pharmacyclics; sandoz; Seagen
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); ADC Therapeutics (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - Abbvie; Celgene; Genentech/Roche; Juno Therapeutics; Millennium; Seagen
 
William R Macon
No Relationships to Disclose